29 July-1 August 2007│Seattle, Washington, USA
Coverage of Microbicides at ISSTDR
Recent developments in microbicide science were featured at the 17th International Society for Sexually Transmitted Disease Research (ISSTDR) conference in Seattle, Washington on 29 July - 1 August. An overview of selected research presented at the conference is in The Microbicide Quarterly.
Conference Information
Website: http://www.isstdr.org/
| Important Dates |
| Early Registration |
1 February 2007 |
| Abstract Submission |
7 March 2007 |
| General Registration |
10 May 2007 |
| Conference |
22-25 July 2007 |
Program, Abstracts & Speakers
Program at-a-Glance
General Announcement
Scientific Program & Abstracts
Online Version of the Abstract CD-ROM
Overview
The International Society for Sexually Transmitted Diseases Research (ISSTDR) conducts biennial meetings that address the entire range of the biomedical, behavioral and social sciences related to all STDs, including human immunodeficiency virus infection. ISSTDR and International Union against Sexually Transmitted Infections (IUSTI) jointly conducted the 17th ISSTDR/10th IUSTI in Seattle, Washington on 29 July - 1 August 2007.
Scientific Tracks
Clinical Research
Diagnosis; treatment; vaccine efficacy; syndromic management; individual level medical intervention research outcomes (i.e. circumcision, microbicides)
Epidemiology
Surveillance, selective screening, prevalence/incidence studies; community/population-level intervention research outcomes; mathematical modeling; molecular epidemiology
Social and Behavioral Aspects of Epidemiology and Prevention
Social and behavioral determinants of behavior change; epidemiology of sexual behavior; behavioral intervention research (including studies on disinhibition that might result from these interventions); acceptability of medical prevention interventions; adherence to interventions; structural and economic interventions
Basic Science Research
New etiologic agents (molecular genomics, antigen discovery), host-pathogen interactions (pathogenesis), vaccine development, typing schemes (genotype/serotype)
Health Services and Policy
Emphasize research component of program evaluation, including development of effective health policy or health services; measurement of impact of health policy or health services on incidence/prevalence of STI and related outcomes. Examples: implementation of chlamydia control programs; syphilis elimination efforts; male circumcision programs; HPV immunization policy and implementation challenges
